Business Wire

Revance to Present New Data on DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia at the Association of Academic Physiatrists Annual Meeting

Revance to Present New Data on DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia at the Association of Academic Physiatrists Annual Meeting - New data ...
Healthline

About Trigger Point Injections for Neck Pain

Trigger point injections may help relieve chronic muscle pain, including pain in your neck. These injections target “knots” in your muscles called trigger points that can cause pain, stiffness, and ...
Nasdaq

Revance Announces U.S. FDA Acceptance of Supplemental Biologics License Application (sBLA) for DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical ...

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License ...
Business Wire

Revance Submits Supplemental Biologics License Application (sBLA) for DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC) a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that it has submitted a ...
Seeking Alpha

With Interim Data In April, A Huge Catalyst Lies Ahead For Neuralstem

Dr. Feldman will give interim data results for CUR's Phase 2 ALS trial in April. Cervical injections could be key to phase 2 success. We now have confirmation from a patient that her breathing and ...